Enhancing effects of agelasphin-11 on natural killer cell activities of normal and tumor-bearing mice

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 3, 1996, Pages 350-353

  Kobayashi, Eiichi ^a   Motoki, Kazuhiro ^a   Natori, Takenori ^a   Uchida, Takeshi ^a   Fukushima, Hideaki ^a   Koezuka, Yasuhiko ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

agelasphin; antitumor agent; immunostimulating agent; natural killer cell; galactosylceramide

Indexed keywords

AGELASPHIN 11; ANTINEOPLASTIC AGENT; GALACTOSYLCERAMIDE; IMMUNOSTIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; FEMALE; GROWTH INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; SPLEEN CELL; SPONGE (PORIFERA); TUMOR GROWTH;

EID: 0030010277     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.350     Document Type: Article

References (13)

1. Evans J. S., Musser E. A., Bostwick L., Mengel G. D., Cancer Res., 24, 1285-1293 (1964).
2. Pettit G R., Kawano Y., Aoyagi R., Herald C. L , Doubek D. L., Schmidt J. M , Rudloe J. J., Tetrahedron, 41.985-994 (1985).
3. Natori T., Koezuka Y , Higa, T., Tetrahedron Lett., 34, 5591-5592 (1993).
4. Natori T., Morita M., Akimoto K., Koezuka Y., Tetrahedron. 50, 2771-2784 (1994).
5. Motoki K., Kobayashi E., Uchida T., Fukushima H., Koezuka Y., Bioorg. Med Chem. Lett., 5, 705-710 (1995).
6. Oldham R. K., J. Natl. Cancer Inst., 70, 789-796 (1983).
7. Herberman R. B., Ortaldo J. R., Science. 214, 24-30 (1981).
8. Talmadge J. E.. Herberman R. B., Chirigos M. A., Maluish A. E., Schneider M. A., Adams J. S., Philips H., Thurman G. B., Varesio L., Long C., Oldham R. K., Wiltrout R. H., J. Immunol., 135, 2483-2491 (1985).
9. Saito M., Ichimura O., Kataoka M , Moriya Y., Ueno K., Sugawara Y., Nanjo M., Ishida N., Cancer Immunol. Immunother., 22, 161-168 (1986).
10. Akiyama Y., Hamuro J., Tanpakushitsu Kokusan Kaso, 26, 208-224 (1981).
11. Hosokawa M., Biotherapy, 5, 1960-1968 (1991).
12. Gresser I., Maury C., Woodrow D., Moss J., Grutter M. G., Vignaux F , Belardelli F., Maunoury M T., Int. J. Cancer, 41, 135-142 (1988).
13. Kedar E., Klein E., Adv. Cancer Res., 59, 245-322 (1993).